Sage Therapeutics
SAGE
#6857
Rank
€0.38 B
Marketcap
6,28 €
Share price
-3.60%
Change (1 day)
-66.35%
Change (1 year)

EPS for Sage Therapeutics (SAGE)

EPS in 2023 (TTM): -9,38 €

According to Sage Therapeutics 's latest financial reports the company's current EPS (TTM) is -8,95 €. In 2022 the company made an earnings per share (EPS) of -8,10 € a decrease over its 2021 EPS that were of -7,04 €.

EPS history for Sage Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-9,38 €15.8%
2022-8,10 €15.13%
2021-7,04 €-167.18%
202010,48 €-186.77%
2019-12,07 €66.21%
2018-7,26 €13.06%
2017-6,43 €51.49%
2016-4,24 €38.64%
2015-3,06 €104.43%
2014-1,50 €52.1%
2013-0,98 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,53 €-82.96%🇺🇸 USA
0,83 €-109.27%🇺🇸 USA
1,73 €-119.35%🇮🇪 Ireland
5,77 €-164.42%🇺🇸 USA